Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | — | 39.3B | 35.1B | 30.0B |
Cost of revenue | — | 10.6B | 8.9B | 7.5B |
Gross profit | — | 28.7B | 26.2B | 22.6B |
Operating expense | ||||
Research & development | — | 3.7B | 3.4B | 3.1B |
Selling general and admin | — | 975M | 897M | 842M |
Other operating expenses | — | — | — | — |
Operating income | — | 24.0B | 21.9B | 18.6B |
Non operating interest income | ||||
Income | — | 511M | 472M | 444M |
Expense | — | 61M | 61M | 61M |
Other income expense | — | 733M | 36M | 189M |
Pretax income | — | 25.2B | 22.3B | 19.2B |
Tax provision | — | 3.1B | 3.0B | 2.6B |
Net income | — | 22.1B | 19.3B | 16.6B |
Basic EPS | — | 0.9 | 0.8 | 0.7 |
Diluted EPS | — | 0.9 | 0.8 | 0.7 |
Basic average shares | 24.4B | 24.5B | 24.5B | 24.6B |
Diluted average shares | 24.6B | 24.7B | 24.8B | 24.8B |
EBITDA | — | 25.8B | 22.9B | 19.7B |
Net income from continuing op. | — | 22.1B | 19.3B | 16.6B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |